These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27537834)

  • 1. Admixture and ethno-specific alleles: missing links for global pharmacogenomics.
    Duconge J; Ruaño G
    Pharmacogenomics; 2016 Sep; 17(14):1479-82. PubMed ID: 27537834
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics and warfarin.
    Anderson DC
    Am J Health Syst Pharm; 2009 Jan; 66(2):121. PubMed ID: 19139475
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics and the management of oral anticoagulation.
    Wittkowsky AK
    Curr Hematol Rep; 2004 Sep; 3(5):363-7. PubMed ID: 15341704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
    Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of CYP2C9 and interindividual variability in anticoagulant response to warfarin.
    Takahashi H; Echizen H
    Pharmacogenomics J; 2003; 3(4):202-14. PubMed ID: 12931134
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacogenomics for warfarin and health economics].
    Ohta N; Miyamoto Y
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():275-9. PubMed ID: 20979282
    [No Abstract]   [Full Text] [Related]  

  • 7. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?
    Baker WL; Chamberlin KW
    Clin Pharmacol Ther; 2014 Jul; 96(1):17-9. PubMed ID: 24942397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of pharmacogenetics in anticoagulation therapy.
    Hill CE; Duncan A
    Clin Lab Med; 2008 Dec; 28(4):513-24. PubMed ID: 19059059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of a Pharmacogenetic-Guided Algorithm to Predict Optimal Warfarin Dosing in a High-Risk Hispanic Patient: Role of a Novel
    Hernandez-Suarez DF; Claudio-Campos K; Mirabal-Arroyo JE; Torres-Hernández BA; López-Candales A; Melin K; Duconge J
    J Investig Med High Impact Case Rep; 2016; 4(4):2324709616682049. PubMed ID: 28210634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.
    Claudio-Campos K; Duconge J; Cadilla CL; Ruaño G
    Drug Metab Pers Ther; 2015 Jun; 30(2):87-105. PubMed ID: 25431893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics--ready for prime time?
    Shurin SB; Nabel EG
    N Engl J Med; 2008 Mar; 358(10):1061-3. PubMed ID: 18322288
    [No Abstract]   [Full Text] [Related]  

  • 13. More on pharmacogenomics and warfarin.
    Anderson DC
    Am J Health Syst Pharm; 2009 Jul; 66(14):1256-7. PubMed ID: 19574598
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.
    George J; Doney A; Palmer CN; Lang CC
    Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomic considerations for customizing warfarin therapy in the orthopedic patient.
    Rhee S; Walsh K; Lewis D; Davis G; Smith KM
    Orthopedics; 2010 Nov; 33(11):828. PubMed ID: 21053849
    [No Abstract]   [Full Text] [Related]  

  • 16. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
    Avery PJ; Jorgensen A; Hamberg AK; Wadelius M; Pirmohamed M; Kamali F;
    Clin Pharmacol Ther; 2011 Nov; 90(5):701-6. PubMed ID: 22012312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and warfarin therapy.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.
    Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM
    PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic pharmacogenetic models in anticoagulation therapy.
    Bon Homme M; Reynolds KK; Valdes R; Linder MW
    Clin Lab Med; 2008 Dec; 28(4):539-52. PubMed ID: 19059061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic evaluation of warfarin pharmacogenomics.
    You JH
    Expert Opin Pharmacother; 2011 Feb; 12(3):435-41. PubMed ID: 21231897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.